All articles tagged: Malignant neoplasm of unspecified part of unspecified bronchus or lung (C34.90)
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
![]()
Evalytics
15 April at 05.54 PM
Accelerated aging linked to cancer risk in younger adults, research showsYounger adults are experiencing increased cancer rates, possibly linked to accelerated biological aging. Researchers analyzed data from the UK Biobank, finding associations between faster aging and higher cancer risks. This study suggests potential for targeted screenings and interventions based on accelerated aging markers to mitigate cancer risks in younger individuals. |
![]()
Evalytics
05 March at 06.03 AM
Metformin's Potential Beyond Diabetes: Exploring Diverse Health BenefitsMetformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp |
![]()
Evalytics
14 February at 06.30 PM
Toby Keith’s Death Raises Questions About Stomach Cancer Symptoms, TreatmentToby Keith, a beloved figure in the country music scene, has recently passed away, leaving fans and the music industry in mourning. However, his death has also brought attention to an important health issue: stomach cancer. In this article, we’ll delve into the details of stomach cancer, Toby Keith’s battle with the disease, and what can be learned from his experience. |
![]()
HealthDay
29 January at 07.24 PM
Philips Suspends U.S. Sales of CPAP, Ventilator Machines After RecallFollowing a recall of millions of its breathing machines that began in mid-2021, Philips Respironics announced Monday that it would halt sales of all such machines within the United States.The machines include continuous positive airway pressure (CPAP) devices used by people with sleep apnea, as well as ventilators used by other patients. <p |
![]()
HealthDay
29 January at 04.07 PM
High-Frequency Jet Ventilation Seems Safe for Lung AblationFor percutaneous lung ablation, high-frequency jet ventilation (HFJV) under general anesthesia seems as safe as spontaneous respiration (SR) under moderate sedation, with longer room time for HFJV, according to a study published online Jan. 24 in the American Journal of Roentgenology.Alexander Graur, from Massachusetts General Hospital |
![]()
HealthDay
18 January at 04.22 PM
Age-Adjusted Cancer Mortality Rates Decreased From 2000 to 2020From 2000 to 2020, U.S. age-adjusted cancer mortality rates decreased significantly, but racial and ethnic disparities persisted for certain cancers, according to a research letter published online Jan. 12 in JAMA Health Forum.Anjali Gupta and Tomi Akinyemiju, Ph.D., from the Duke University School of Medicine in Durham, North Carolin |
![]()
HealthDay
16 January at 04.57 PM
Chemoradiation With SABR Boost Safe, Effective for Advanced Lung CancerChemoradiation with an adaptive stereotactic ablative radiotherapy (SABR) boost is safe and effective for patients with locally advanced, unresectable non–small cell lung cancer (NSCLC), according to a study published online Jan. 11 in JAMA Oncology.Trudy C. Wu, M.D., from the University of California in Los Angeles, and colleagues exa |
![]()
HealthDay
11 January at 06.16 PM
End-of-Life Treatment With Immunotherapy Increasing for Patients With CancerInitiation of immunotherapy for metastatic cancer at the end of life (EOL) is increasing over time, according to a study published online Jan. 4 in JAMA Oncology.Daniel M. Kerekes, M.D., from Yale University in New Haven, Connecticut, and colleagues examined patient characteristics, practice patterns, and risk factors concerning |
![]()
HealthDay
02 January at 04.59 PM
Study IDs Downstream Procedure, Complication Rates After Lung Cancer ScreeningFor individuals undergoing low-dose computed tomography (LDCT) scans for lung cancer screening (LCS), the rates of downstream procedures and complications are higher than observed in the National Lung Screening Trial (NLST), according to a study published online Jan. 2 in the Annals of Internal Medicine.Katharine A. Rendle, Ph.D., M.P.H |
![]()
Evalytics
22 December at 04.11 PM
A known carcinogen is showing up in wildfire ash, and researchers are worriedThe NPR article reports elevated levels of the carcinogen chromium-6 in wildfire ash, potentially posing health risks like lung cancer due to inhalation. Researchers call for further investigation and protective measures in affected areas. |
![]()
HealthDay
19 December at 04.59 AM
Outdoor Pollution Exposure Tied to Nonlung CancersOutdoor air pollution is tied to a higher risk for nonlung cancers in older adults, according to a study published online Aug. 1 in Environmental Epidemiology.Yaguang Wei, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined associations of 10-year exposures to fine particulate matter (PM2. |
![]()
HealthDay
13 December at 03.45 PM
Study Looks at Survival in Metastatic NSCLC Treated With ImmunotherapyFor patients with metastatic non-small cell lung cancer (NSCLC) receiving immunotherapy, outcomes are similar across racial and ethnic groups, but ECOG performance status (PS) is associated with survival, according to a study published online Dec. 11 in the Journal of the National Comprehensive Cancer Network.Matthew Lee, M.D., M.P.H |
![]()
HealthDay
13 December at 03.33 PM
Increasing Body Mass Index Tied to 18 Site-Specific Cancers in MenIncreasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer ( |
![]()
HealthDay
08 December at 04.54 PM
Radiological Society of North America, Nov. 26-30The annual meeting of the Radiological Society of North America was held from Nov. 26 to 30 in Chicago, drawing nearly 25,000 participants, including radiologists, radiation oncologists, physicists in medicine, radiologic technologists, and other health care professionals. The conference featured scientific papers from a number of subspecialtie |
![]()
HealthDay
16 November at 04.33 PM
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLCFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), osimertinib with chemotherapy leads to significantly longer progression-free survival (PFS) compared with osimertinib alone, according to a study published online Nov. 8 in the New England Journal of Medicine.David Planchard, M.D., Ph.D., from Institu |
![]()
HealthDay
14 November at 04.29 PM
Rate of New Lung Cancer Cases Has Decreased Over Last Five YearsThe rate of new lung cancer cases has decreased and survival has improved over the last five years, according to the State of Lung Cancer 2023 report published Nov. 14 by the American Lung Association.In the report, researchers present the latest national and state-by-state lung cancer data, including new cases, survival, early diagnosis, and s |
![]()
HealthDay
09 November at 03.58 PM
2023 Guidelines Update Eligibility for Lung Cancer ScreeningIn a guideline update issued by the American Cancer Society and published online Nov. 1 in CA: A Cancer Journal for Clinicians, the authors recommend increasing eligibility for lung cancer screening (LCS).Andrew M.D. Wolf, M.D., from the University of Virginia School of Medicine in Charlottesville, and colleagues updated the American C |
![]()
Evalytics
06 November at 04.03 PM
Study shows that smoking 'stops' cancer-fighting proteins, causing cancer and making it harder to treatA study by the Ontario Institute for Cancer Research links tobacco smoking to DNA mutations that disrupt cancer-fighting proteins, increasing cancer risk and complicating treatment. The more one smokes, the more mutations occur, particularly in lung cancer, highlighting smoking's severe impact on cellular health and cancer development. |
![]()
Evalytics
06 November at 03.05 PM
More adults should be screened for lung cancer under updated guideline, American Cancer Society saysThe American Cancer Society has updated its lung cancer screening guidelines to include adults aged 50-80 with a significant smoking history, regardless of how long ago they quit. This expansion could prevent 21% more lung cancer deaths and is aimed at improving early detection, especially in high-risk communities. |
![]()
HealthDay
30 October at 03.55 PM
American College of Chest Physicians, Oct. 8-11The annual meeting of the American College of Chest Physicians was held this year from Oct. 8 to 11 in Honolulu and attracted participants from around the world, including specialists and heath care professionals focused on pulmonary medicine, critical care, and sleep medicine. The conference feat |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |